Search research articles
Contact Us
Filters
Showing results (41-50 of 63) with videos related to
Page
of 7
Sort By:
The New England Journal of Medicine
|
August 26, 1976
The histologic spectrum of Barrett's esophagus
A Paull, J S Trier, M D Dalton, et al.
Rheumatology International
|
January 1, 1986
Aberrant lymphocyte trafficking in murine systemic lupus erythematosus
L Schrieber, A D Steinberg, Y J Rosenberg, et al.
Molecules (Basel, Switzerland)
|
July 2, 2021
Topical Astodrimer Sodium, a Non-Toxic Polyanionic Dendrimer, Demonstrates Antiviral Activity in an Experimental Ocular Adenovirus Infection Model
Eric G Romanowski, Kathleen A Yates, Jeremy R A Paull, et al.
Antimicrobial Agents and Chemotherapy
|
June 17, 2009
Enhancement of human immunodeficiency virus type 1 replication is not intrinsic to all polyanion-based microbicides
Secondo Sonza, Adam Johnson, David Tyssen, et al.
Viruses
|
August 28, 2021
Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice
Jeremy R A Paull, Carolyn A Luscombe, Alex Castellarnau, et al.
Sexually Transmitted Diseases
|
October 14, 2009
Safety, tolerability, and pharmacokinetics of SPL7013 gel (VivaGel): a dose ranging, phase I study
John O'Loughlin, Iona Y Millwood, Helen M McDonald, et al.
Plos One
|
February 12, 2011
A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel®) in healthy young women administered twice daily for 14 days
Craig R Cohen, Joelle Brown, Anna-Barbara Moscicki, et al.
Pharmaceutics
|
September 28, 2024
Astodrimer Sodium Nasal Spray versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blinded, Placebo-Controlled Trial
Stephen Winchester, Alex Castellarnau, Kashif Jabbar, et al.
Antiviral Research
|
May 19, 2021
Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro
Jeremy R A Paull, Graham P Heery, Michael D Bobardt, et al.
Scientific Reports
|
June 17, 2022
Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial
Alex Castellarnau, Graham P Heery, Aynaz Seta, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 63) with videos related to
Sort By:
Page
of 7
The New England Journal of Medicine
|
August 26, 1976
The histologic spectrum of Barrett's esophagus
A Paull, J S Trier, M D Dalton, et al.
Rheumatology International
|
January 1, 1986
Aberrant lymphocyte trafficking in murine systemic lupus erythematosus
L Schrieber, A D Steinberg, Y J Rosenberg, et al.
Molecules (Basel, Switzerland)
|
July 2, 2021
Topical Astodrimer Sodium, a Non-Toxic Polyanionic Dendrimer, Demonstrates Antiviral Activity in an Experimental Ocular Adenovirus Infection Model
Eric G Romanowski, Kathleen A Yates, Jeremy R A Paull, et al.
Antimicrobial Agents and Chemotherapy
|
June 17, 2009
Enhancement of human immunodeficiency virus type 1 replication is not intrinsic to all polyanion-based microbicides
Secondo Sonza, Adam Johnson, David Tyssen, et al.
Viruses
|
August 28, 2021
Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice
Jeremy R A Paull, Carolyn A Luscombe, Alex Castellarnau, et al.
Sexually Transmitted Diseases
|
October 14, 2009
Safety, tolerability, and pharmacokinetics of SPL7013 gel (VivaGel): a dose ranging, phase I study
John O'Loughlin, Iona Y Millwood, Helen M McDonald, et al.
Plos One
|
February 12, 2011
A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel®) in healthy young women administered twice daily for 14 days
Craig R Cohen, Joelle Brown, Anna-Barbara Moscicki, et al.
Pharmaceutics
|
September 28, 2024
Astodrimer Sodium Nasal Spray versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blinded, Placebo-Controlled Trial
Stephen Winchester, Alex Castellarnau, Kashif Jabbar, et al.
Antiviral Research
|
May 19, 2021
Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro
Jeremy R A Paull, Graham P Heery, Michael D Bobardt, et al.
Scientific Reports
|
June 17, 2022
Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial
Alex Castellarnau, Graham P Heery, Aynaz Seta, et al.
Page
of 7